NDC 53157-000

LeukoTrap SOLX B Additive

As-7 B Additive Solution

LeukoTrap SOLX B Additive is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Haemonetics Manufacturing Inc. The primary component is Dextrose, Unspecified Form.

Product ID53157-000_eab5a1f9-bed2-4a42-9544-d5912cd267b8
NDC53157-000
Product TypeHuman Prescription Drug
Proprietary NameLeukoTrap SOLX B Additive
Generic NameAs-7 B Additive Solution
Dosage FormSolution
Route of AdministrationINTRAVENOUS
Marketing Start Date2015-11-12
Marketing CategoryNDA / NDA
Application NumberNDA110059
Labeler NameHaemonetics Manufacturing Inc
Substance NameDEXTROSE, UNSPECIFIED FORM
Active Ingredient Strength2 g/30mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 53157-000-00

30 mL in 1 BAG (53157-000-00)
Marketing Start Date2015-11-12
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53157-000-00 [53157000000]

LeukoTrap SOLX B Additive SOLUTION
Marketing CategoryNDA
Application NumberNDA110059
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-11-12
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
DEXTROSE, UNSPECIFIED FORM1.78 g/30mL

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.